Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495271 · ClinicalTrials.gov registry record

Pilot Study of Taste Sensations in Patients With End-stage Renal Disease on Hemodialysis

A clinical trial, sponsored by Purdue University.

Completed
Registry status
55
Enrollment target

NCT03495271 is a clinical trial that has completed, run by Purdue University. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495271 has completed, sponsored by Purdue University.

COMPLETED
Registry status
55 participants
Enrollment target

Study Summary

Individuals on dialysis due to kidney failure have very prescriptive diets. These diets help increase dialysis effectiveness and help patients control blood levels of electrolytes including potassium and phosphate, acid-base balance, blood pressure, and fluid between dialysis treatments. However, patient compliance with these diets often can be very low, and one reason for this low compliance is disguesia (abnormal taste sensations) which can make the diets unpalatable. This experiment tests the hypothesis that disguesia, and subsequent lack of adherence to a dialysis friendly diet, is a result of either vascular taste (tasting your own blood through the basolateral side of taste cells) or altered chemical composition of saliva in between dialysis appointments. However, to study these hypotheses, data are needed on the types of substances that may contribute to the disguesia. Substances for which the concentration is influenced by kidney function (in healthy people) or dialysis (in patients) are the prime candidates for the disguesia under our hypotheses. Thus, this experiment tests whether taste or flavours experienced from sodium, calcium, potassium, creatinine, urea, phosphates, glutamate, and iron may be related to altered taste experienced by patients on dialysis.

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2017-02-06
Est. Completion 2017-04-19

Sponsor

Purdue University

141 total trials

What the Registry Record Tells You About NCT03495271

The ClinicalTrials.gov registry entry for NCT03495271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03495271 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03495271 about?

NCT03495271 is a clinical study titled "Pilot Study of Taste Sensations in Patients With End-stage Renal Disease on Hemodialysis". Individuals on dialysis due to kidney failure have very prescriptive diets. These diets help increase dialysis effectiveness and help patients control blood levels of electrolytes including potassium and phosphate, acid-base balance, blood pressure, and fluid between dialysis treatments. However, pa...

What is the current status of trial NCT03495271?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2017-02-06. Estimated completion is 2017-04-19.

Who is sponsoring clinical trial NCT03495271?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.